Paratek Pharmaceuticals, Inc. (PRTK) Social Stream



Paratek Pharmaceuticals, Inc. (PRTK): $1.97

-0.09 (-4.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRTK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Paratek Pharmaceuticals Inc (PRTK) Price Targets From Analysts

Use the tables below to see what analysts covering Paratek Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $27 $10 $17.333 $2.94 489.56%
2022-02-10 3 $27 $11 $17.666 $2.94 500.88%
2022-03-14 3 $27 $11 $17 $2.94 478.23%
2022-03-17 3 $22 $11 $15.333 $2.94 421.53%

The Trend in the Analyst Price Target


PRTK's average price target has moved down $3.07 over the prior 45 weeks.

PRTK reports an average of 246.62% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 3 34 11 20.500 8.01 155.93%
2021-06-13 5 34 10 18.400 10.72 71.64%
2021-06-26 5 34 10 19.600 7.01 179.6%
2021-07-03 5 34 10 19.600 6.94 182.42%
2022-02-10 2 27 11 17.666 3.99 342.76%

PRTK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


PRTK's average broker recommendation rating improved by 0.5 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTK as an investment opportunity.

  • Paratek Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 576.41% of all US stocks.
  • PRTK has a higher number of analysts covering the stock than 49.27% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Paratek Pharmaceuticals Inc's variance in analysts' estimates is lower than -434.35% of them.
  • In the context of Healthcare stocks, Paratek Pharmaceuticals Inc's average analyst price target is greater than 170.4% of them.

In the Pharmaceutical Products industry, PRTC, PRQR, and PROC are the three stocks most similar to Paratek Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding PRTK using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5628 seconds.